Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer-Reference-Cited by-同舟云学术

Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer

Published:2024-06-24 Issue:26 Volume:18 Page:16516-16529
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Chargari Cyrus¹²,Maury Pauline¹²,Texier Matthieu³,Genestie Catherine⁴,Morice Philippe⁵,Bockel Sophie¹²,Gouy Sébastien⁵,Ba Mouhamadou¹,Achkar Samir¹,Lux François⁶⁷,Tillement Olivier⁶,Dufort Sandrine⁸,Duc Géraldine L.E.⁸,Debeaumont Olivier⁸,Massard Christophe⁹¹⁰¹¹¹²,Maulard Amandine⁴,Porcel Erika⁹,Bahleda Ratislav¹⁰,Ammari Samy¹³,Morel Daphné¹²,Espenel Sophie¹,Pautier Patricia¹¹,Robert Charlotte¹²¹¹¹²,Deutsch Eric¹²¹¹¹²^ORCID

Affiliation:

1. Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif 94805, France

2. INSERM1030 Molecular Radiotherapy and Therapeutic Innovation Gustave Roussy Cancer Campus, Villejuif 94805, France

3. Biostatistics Unit, Gustave Roussy Cancer Campus, Villejuif 94805, France

4. Department of Pathology, Gustave Roussy Cancer Campus, Villejuif 94805, France

5. Department of Surgery, Gustave Roussy Cancer Campus, Villejuif 94805, France

6. Institut Lumière-Matière, UMR 5306, Université Lyon1-CNRS, Université de Lyon, Villeurbanne Cedex 69622 Villeurbanne, France

7. Institut Universitaire de France, 75231 Paris, France

8. NH TherAguix SA, 38240 Meylan, France

9. Université Paris-Saclay, CNRS, Institut des Sciences Moléculaires d’Orsay, 91405 Orsay, France

10. Département d’Innovation Thérapeutique et d’Essais Précoces, Gustave Roussy Cancer Campus, Villejuif 94805, France

11. Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif 94805, France

12. University Paris-Saclay Faculty of Medicine, Le Kremlin, Bicêtre 94270, France

13. Department of Radiology, Gustave Roussy Cancer Campus, Villejuif 94805, France

Funder

Institut National Du Cancer

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c12537

Reference34 articles.

1. Combined modality including novel sensitizers in gynecological cancers

2. Clinical transfer of AGuIX®-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework

3. Nanoparticles in radiation oncology: From bench-side to bedside

4. Integrating nanomedicine into clinical radiotherapy regimens

Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy